Top-line Results Due by Year’s End for Just-completed P2B001 Trial

Top-line Results Due by Year’s End for Just-completed P2B001 Trial

306754

Top-line Results Due by Year’s End for Just-completed P2B001 Trial

Top-line results are expected to be released by the end of this year for Pharma Two B’s multinational trial investigating the safety and efficacy of P2B001 for treating early stage Parkinson’s disease. Pharma Two B announced that its researchers have finished treating patients in the Phase 3 trial, which launched in 2017. “We are pleased to announce the completion of the last patient visit in this Phase III study, which represents an important milestone for Pharma Two…

You must be logged in to read/download the full post.